Immunicum to Participate in Multiple Upcoming Industry and Investor Events in November

NEXT STORY
Covis Significantly Strengthens Global Respiratory Portfolio Through Acquisition of Two Medicines from AstraZeneca
PREV STORY
Valneva Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Global Offering to Approximately $102.0 Million
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Valneva Appoints MVM Partner Thomas Casdagli to its Supervisory Board

author_avatar
NASDAQ Market News

Leap Therapeutics Provides DKN-01 Program Update and Announces Scientific Presentations at AACR Annual Meeting

CAMBRIDGE, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology ...

author_avatar
NASDAQ Market News

Global Genetic Testing Market 2017-2020 – Genomic Discoveries and Direct to Consumer Drive Growth in a New Genetic Testing Industry

Dublin, March 20, 2018 (GLOBE NEWSWIRE) -- The "The Global Genetic Testing Market 2017 ...

author_avatar
NASDAQ Market News